3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Recruiting
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Lung Neoplasms
18
Hematologic Neoplasms
10
Prostatic Neoplasms
9
Colorectal Neoplasms
9
Breast Neoplasms
9
Hematopoietic and Lymphatic System Neoplasm
8
Carcinoma, Non-Small-Cell Lung
7
Anatomic Stage I Breast Cancer AJCC v8
7
Pancreatic Neoplasms
6
Neoplasm Metastasis
6
Uterine Cervical Neoplasms
5
Urinary Bladder Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
4
Ovarian Neoplasms
4
Neoplasms
4
Hematopoietic and Lymphoid System Neoplasm
4
Head and Neck Carcinoma
4
Breast Carcinoma In Situ
4
Triple Negative Breast Neoplasms
3
Multiple Myeloma
3
Melanoma
3
Malignant Solid Neoplasm
3
Lymphoma
3
Leukemia, Myeloid, Acute
3
Carcinoma, Renal Cell
3
Stomach Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Papillomavirus Infections
2
Mouth Neoplasms
2
Head and Neck Neoplasms
2
Interventions
Paclitaxel
8
Hyperthermic Intraperitoneal Chemotherapy
6
Mitomycin
5
Cisplatin
5
Fluorouracil
4
Bevacizumab
4
Oxaliplatin
3
Leucovorin
3
Doxorubicin
3
Cytoreduction Surgical Procedures
3
Carboplatin
3
Blood Specimen Collection
3
sodium thiosulfate
2
pembrolizumab
2
Standard of Care
2
Laparoscopy
2
soluble LAG-3 protein, human
1
relacorilant
1
oregovomab
1
olaparib
1
nilotinib
1
liposomal doxorubicin
1
irinotecan sucrosofate
1
dehydroftorafur
1
avelumab
1
X-Rays
1
Topotecan
1
Taxes
1
Specimen Handling
1
Saline Solution
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Peritoneal Neoplasms
×
Practice Guidelines as Topic
×
1 year
×
Clear all
NCT07001748
2026-05-15
STOPGAP II
Eastern Cooperative Oncology Group
Phase 2/3
Recruiting
148 enrolled